DiaMedica Therapeutics Inc.

US$9.36As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DMACHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (114.61%)
Biotechnology
Beta (5Y) 0.94
PE TTM —
TSR TTM 32.58%
Mkt cap US$504.7M
ROIC (74.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
14.92%
(72.46%)
Sell 5|10|4|0|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.12
0.13
6.62%
10.63%
(0.43%)
9.44%
Revenue$M
25.89
26.59
27.50
28.55
4.62%
2.12%
8.75%
10.83%
Peers (US$504.7M)
Cap (US$)
PE
506.5M
—
503.9M
—
Capital
TTM
5Y
10Y
Leveragex
1.056
(0.228)
(0.211)
EBIT/Intx
1.607
0.125
0.151
Own earn%
100.25
117.04
107.31
Sh yield%
22.34
34.98
33.49
Owners
Insiders/Inst%
8.05
86.52
Short interest%
5.61
SBC / revenue%
1.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
18–22
$1 testx
0.0
Incr. ROIC%
6